Condition
Vulvodynia (Chronic Vulvar Pain)
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting3
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06999395Not ApplicableRecruitingPrimary
Does a Virtual Program for Pelvic Pain Improve Pain and Sexual Outcomes in Individuals With Provoked Vestibulodynia?
NCT06840314Not ApplicableRecruiting
VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia
NCT06981611Not ApplicableRecruitingPrimary
Vulvodynia Intervention: the Effect of Multimodal Treatment for Provoked Vulvodynia
NCT00390013Not ApplicableTerminated
To Evaluate if the Medication Gabapentin Lessens Vulvar Pain
Showing all 4 trials